2014-07-01 23:52:21 UTC

CGH Podcast July 2014: Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients

A “Perspectives in Clinical Gastroenterology and Hepatology” article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with nonalcoholic fatty liver disease (NAFLD). Dr. Kuemmerle speaks to first author Dr. Kathleen E. Corey of the Department of Medicine, Gastrointestinal Unit, Massachusetts General Hospital; Plus, summaries of top stories from this month's issue of GI and Hepatology News.

 

 

Corey KE, Chalasani N. Management of Dyslipidemia as a Cardiovascular Risk Factor in Individuals With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology & Hepatology 2014; July 12(7): 1077-1084
Abstract

 

 

Duration: 13.44m
Filetype: mp3
Bitrate: 96 KBPS
Frequency: 44100 HZ

 

 

More on Non-Alcoholic Fatty Liver Disease (NAFLD)

Blog: How Could Lamins Protect Against Steatohepatitis?

Nov. 8, 2017

Observations show how variants in genes encoding lamins affect risk for steatohepatitis and liver fibrosis. Read more on the AGA Journals blog.

Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective Steatohepatitis

Oct. 22, 2017

Lamin A/C absence leads to male-selective fatty liver disease and predisposes to nonalcoholic steatohepatitis and fibrosis.

Blog: Special 15th Anniversary Collection from Clinical Gastroenterology and Hepatology

Oct. 11, 2017

Celebrate this milestone with a look back at landmark articles, commentaries and reviews. Read more on the AGA Journals blog.